Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses
Author: ["Simona Stäger","James Alexander","Alun C Kirby","Marina Botto","Nico Van Rooijen","Deborah F Smith","Frank Brombacher","Paul M Kaye"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
CD8+ T cells are essential for long-term, vaccine-induced resistance against intracellular pathogens. Here we show that natural antibodies, acting in concert with complement, are endogenous adjuvants for the generation of protective CD8+ T cells after vaccination against visceral leishmaniasis. IL-4 was crucial for the priming of vaccine-specific CD8+ T cells, and we defined the primary source of IL-4 as a CD11b+CD11clo phagocyte. IL-4 secretion was not observed in antibody-deficient mice and could be reconstituted with serum from normal, but not Btk immune-deficient, mice. Similarly, no IL-4 response or CD8+ T-cell priming was seen in C1qa−/− mice. These results identify a new pathway by which immune complex–mediated complement activation can regulate T-cell-mediated immunity. We propose that this function of natural antibodies could be exploited when developing new vaccines for infectious diseases.
Cite this article
Stäger, S., Alexander, J., Kirby, A. et al. Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med 9, 1287–1292 (2003). https://doi.org/10.1038/nm933